Figure 2.

Validative endpoints in relation to LV thrombus detection by DE-CMR. Outcomes-based assessment (cerebrovascular accident, transient ischemic attack, or pathology-verified thrombus) in relation to the diagnosis of thrombus as evaluated in an overall registry of heart failure patients (upper right) as well as a subgroup of patients undergoing both DE-CMR and echo (center). Stratification based on presence (red) or absence (blue) of LV thrombus by DE-CMR yielded over a 7-fold difference in endpoints among patients in the overall registry (P<.001) and a 5-fold difference in the echo sub-group (P = .02), whereas stratification by echo yielded a nonsignificant difference between groups (P = .34). Reprinted from JACC Cardiovasc Imaging, 2011. ©2011; reprinted with permission from Elsevier.7 LV: left ventricular; DE-CMR: delayed-enhancement cardiac magnetic resonance; echo: echocardiography.